Literature DB >> 21952923

Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.

David M Winder1, Anasuya Chattopadhyay, Balaji Muralidhar, Julien Bauer, William R English, Xiao Zhang, Konstantina Karagavriilidou, Ian Roberts, Mark R Pett, Gillian Murphy, Nicholas Coleman.   

Abstract

Oncostatin M receptor (OSMR) shows frequent copy number gain and overexpression in advanced cervical squamous cell carcinoma (SCC). We used cell-based in vitro assays, RNA interference, and integrative gene expression profiling to investigate the functional significance of this observation. CaSki and SW756 were selected as representative cervical SCC cells that overexpressed OSMR, and ME180 and MS751 as cells that did not. The STAT-dependent pro-angiogenic factors VEGF-A and ID1 were rapidly induced by OSM in CaSki/SW756 but not in ME180/MS751. However, rapid induction did occur in MS751 following forced OSMR overexpression, while depleting OSMR in CaSki abrogated VEGF-A expression. Conditioned medium from both CaSki and SW756 stimulated endothelial tube formation in vitro, effects that were inhibited by depleting OSMR in the SCC cells. For both CaSki and SW756, migration in a wound healing assay and invasion through Matrigel were stimulated by OSM and consistently inhibited by OSMR depletion. The phenotype was rescued by transfection with OSMR containing a silent mutation that provided specific siRNA resistance. Overall, there was a positive correlation between OSMR levels and invasiveness. We used gene expression profiling to identify genes induced by OSM in CaSki/SW756 but not in ME180/MS751. The most prominent gene ontology category groups for the differentially expressed genes were cell motility/invasion, angiogenesis, signal transduction, and apoptosis. We also profiled 23 cervical SCC samples, identifying genes that were differentially expressed in cases with OSMR overexpression versus those without. Integration of the datasets identified 15 genes that showed consistent differential expression in association with OSMR levels in vitro and in vivo. We conclude that OSMR overexpression in cervical SCC cells provides increased sensitivity to OSM, which induces pro-malignant changes. OSMR is a potential prognostic and therapeutic target in cervical SCC. The genes that mediate OSM:OSMR effects will be valuable indicators of the effectiveness of antibody blockade in pre-clinical systems.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952923     DOI: 10.1002/path.2968

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

1.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

2.  Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.

Authors:  Wen Wang; Zheng Zhao; Fan Wu; Haoyuan Wang; Jiangfei Wang; Qing Lan; Jizong Zhao
Journal:  J Neurooncol       Date:  2017-11-22       Impact factor: 4.130

3.  Oncostatin M treatment increases the responsiveness toward cisplatin-based chemoradiotherapy in cervical cancer cells in a STAT3-dependent manner.

Authors:  Russalina Stroeder; Barbara Walch-Rückheim; Jil Fischbach; Ingolf Juhasz-Böss; Christian Rübe; Erich-Franz Solomayer; Sigrun Smola
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

4.  JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.

Authors:  Kazuhiko Shien; Vassiliki A Papadimitrakopoulou; Dennis Ruder; Carmen Behrens; Li Shen; Neda Kalhor; Juhee Song; J Jack Lee; Jing Wang; Ximing Tang; Roy S Herbst; Shinichi Toyooka; Luc Girard; John D Minna; Jonathan M Kurie; Ignacio I Wistuba; Julie G Izzo
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

5.  Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.

Authors:  Arezu Jahani-Asl; Hang Yin; Vahab D Soleimani; Takrima Haque; H Artee Luchman; Natasha C Chang; Marie-Claude Sincennes; Sidharth V Puram; Andrew M Scott; Ian A J Lorimer; Theodore J Perkins; Keith L Ligon; Samuel Weiss; Michael A Rudnicki; Azad Bonni
Journal:  Nat Neurosci       Date:  2016-04-25       Impact factor: 24.884

6.  Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.

Authors:  J E Hanning; H K Saini; M J Murray; S van Dongen; M P A Davis; E M Barker; D M Ward; C G Scarpini; A J Enright; M R Pett; N Coleman
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

Review 7.  The enigmatic cytokine oncostatin m and roles in disease.

Authors:  Carl D Richards
Journal:  ISRN Inflamm       Date:  2013-12-08

8.  Profiling of Discrete Gynecological Cancers Reveals Novel Transcriptional Modules and Common Features Shared by Other Cancer Types and Embryonic Stem Cells.

Authors:  Kalliopi I Pappa; Alexander Polyzos; Jasmine Jacob-Hirsch; Ninette Amariglio; George D Vlachos; Dimitrios Loutradis; Nicholas P Anagnou
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

9.  Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.

Authors:  Maria M Caffarel; Anasuya Chattopadhyay; Angela M Araujo; Julien Bauer; Cinzia G Scarpini; Nicholas Coleman
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

Review 10.  Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.

Authors:  Maria M Caffarel; Nicholas Coleman
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.